Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

Rory de Vries; Arwen Altenburg; Nella Nieuwkoop; Erwin de Bruin; Stella Trierum; Mark Pronk; Mart Lamers; Mathilde Richard; David Nieuwenhuijse; Marion Koopmans; Joost Kreijtz; Ron Fouchier; Ab Osterhaus; G Sutter; Guus Rimmelzwaan

doi:10.1093/infdis/jiy214

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

Rory de Vries
, Arwen Altenburg
, Nella Nieuwkoop
, Erwin de Bruin
, Stella Trierum
, Mark Pronk
, Mart Lamers
, Mathilde Richard
, David Nieuwenhuijse
, Marion Koopmans
, Joost Kreijtz
, Ron Fouchier
, Ab Osterhaus
, G Sutter
, Guus Rimmelzwaan

Virology

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	614-623
Number of pages	10
Journal	Journal of Infectious Diseases
Volume	218
Issue number	4
DOIs	https://doi.org/10.1093/infdis/jiy214
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC OR-01

Access to Document

10.1093/infdis/jiy214

http://hdl.handle.net/1765/109655

Cite this

de Vries, R., Altenburg, A., Nieuwkoop, N., de Bruin, E., Trierum, S., Pronk, M., Lamers, M., Richard, M., Nieuwenhuijse, D., Koopmans, M., Kreijtz, J., Fouchier, R., Osterhaus, A., Sutter, G., & Rimmelzwaan, G. (2018). Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. Journal of Infectious Diseases, 218(4), 614-623. https://doi.org/10.1093/infdis/jiy214

@article{177990b9cae6439e91941d43588ae00a,

title = "Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial",

author = "\{de Vries\}, Rory and Arwen Altenburg and Nella Nieuwkoop and \{de Bruin\}, Erwin and Stella Trierum and Mark Pronk and Mart Lamers and Mathilde Richard and David Nieuwenhuijse and Marion Koopmans and Joost Kreijtz and Ron Fouchier and Ab Osterhaus and G Sutter and Guus Rimmelzwaan",

year = "2018",

doi = "10.1093/infdis/jiy214",

language = "Undefined/Unknown",

volume = "218",

pages = "614--623",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "4",

}

de Vries, R, Altenburg, A, Nieuwkoop, N, de Bruin, E, Trierum, S, Pronk, M, Lamers, M, Richard, M , Nieuwenhuijse, D , Koopmans, M, Kreijtz, J, Fouchier, R, Osterhaus, A, Sutter, G & Rimmelzwaan, G 2018, 'Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial', Journal of Infectious Diseases, vol. 218, no. 4, pp. 614-623. https://doi.org/10.1093/infdis/jiy214

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. / de Vries, Rory; Altenburg, Arwen; Nieuwkoop, Nella et al.
In: Journal of Infectious Diseases, Vol. 218, No. 4, 2018, p. 614-623.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

AU - de Vries, Rory

AU - Altenburg, Arwen

AU - Nieuwkoop, Nella

AU - de Bruin, Erwin

AU - Trierum, Stella

AU - Pronk, Mark

AU - Lamers, Mart

AU - Richard, Mathilde

AU - Nieuwenhuijse, David

AU - Koopmans, Marion

AU - Kreijtz, Joost

AU - Fouchier, Ron

AU - Osterhaus, Ab

AU - Sutter, G

AU - Rimmelzwaan, Guus

PY - 2018

Y1 - 2018

U2 - 10.1093/infdis/jiy214

DO - 10.1093/infdis/jiy214

M3 - Article

C2 - 29912453

SN - 0022-1899

VL - 218

SP - 614

EP - 623

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 4

ER -